Health Care & Life Sciences » Pharmaceuticals | Sinclair Pharma PLC

Sinclair Pharma PLC | Balance Sheet

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
5,061.00
17,532.00
12,661.00
16,769.00
1,837.00
Total Accounts Receivable
18,050.00
27,511.00
26,020.00
12,526.00
16,940.00
Inventories
4,848.00
7,599.00
7,623.00
3,840.00
4,266.00
Other Current Assets
1,886.00
2,345.00
1,873.00
803.00
-
Total Current Assets
29,845.00
54,987.00
48,177.00
33,938.00
23,043.00
Net Property, Plant & Equipment
500.00
1,399.00
1,712.00
1,679.00
1,574.00
Total Investments and Advances
157.00
163.00
167.00
102.00
167.00
Intangible Assets
121,362.00
241,541.00
232,282.00
148,880.00
144,093.00
Other Assets
-
1,100.00
-
-
-
Total Assets
156,019.00
302,718.00
285,417.00
184,599.00
168,877.00
ST Debt & Current Portion LT Debt
3,418.00
1,240.00
19.00
-
1,039.00
Accounts Payable
8,673.00
14,621.00
12,576.00
4,880.00
6,742.00
Income Tax Payable
311.00
2,075.00
1,923.00
2,667.00
603.00
Other Current Liabilities
11,626.00
26,456.00
33,759.00
20,881.00
11,781.00
Total Current Liabilities
24,028.00
44,392.00
48,277.00
28,428.00
20,165.00
Long-Term Debt
8,500.00
53,319.00
51,779.00
-
3,763.00
Deferred Taxes
6,774.00
21,995.00
22,095.00
22,526.00
19,621.00
Other Liabilities
2,021.00
61,567.00
54,615.00
33,325.00
26,145.00
Total Liabilities
45,478.00
184,801.00
179,845.00
84,279.00
69,694.00
Common Equity (Total)
110,541.00
117,917.00
105,572.00
100,320.00
99,183.00
Total Shareholders' Equity
110,541.00
117,917.00
105,572.00
100,320.00
99,183.00
Total Equity
110,541.00
117,917.00
105,572.00
100,320.00
99,183.00
Liabilities & Shareholders' Equity
156,019.00
302,718.00
285,417.00
184,599.00
168,877.00

About Sinclair Pharma

View Profile
Address
Whitfield Court
London Greater London W1T 2RQ
United Kingdom
Employees -
Website http://sinclairispharma.com
Updated 09/14/2018
Sinclair Pharma Plc is an aesthetic dermatology company, which provides aesthetic dermatology solutions through collagen stimulation for facial volume loss, thread lifting for facial contouring, and dermal fillers for wrinkles and lines. It operates through the following business segments: Country Operations, and International Operations. The Country Operations segment comprises the proprietary sales infrastructure from the operations in France, the United Kingdom, Italy, Germany, and Spain.